Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Aug;65(8):3138–3145. doi: 10.1128/iai.65.8.3138-3145.1997

Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens.

J M Burns Jr 1, P D Dunn 1, D M Russo 1
PMCID: PMC175443  PMID: 9234766

Abstract

The Plasmodium yoelii murine model was used to test several combinations of blood-stage antigens and adjuvants for the ability to induce immunity to blood-stage malaria. Upon fractionation of whole blood-stage antigen into soluble and insoluble components, only the particulate antigens (pAg) induced protective immune responses. Of a number of adjuvants tested, Quil A was the most effective. Immunization with pAg plus Quil A induced solid protection against nonlethal and lethal P. yoelii challenge infection. Analysis of cytokine production revealed mRNA for Th1-type cytokines (interleukin 2 [IL-2] and gamma interferon) as well as Th2-type cytokines (IL-4 and IL-10) in the spleens of both protected and susceptible animals. The data suggested that the protective pAg response was associated with the earlier production of cytokine mRNA with a Th2 phenotype somewhat favored. Immunization of B-cell-deficient JHD mice indicated that the protection against P. yoelii induced by pAg immunization was B cell dependent. Although immunization with pAg plus Quil A increased the levels of antigen-specific antibodies of all four immunoglobulin G (IgG) isotypes, protection correlated most closely with the presence of IgG1 and IgG2b antibodies. Sera from pAg-plus-Quil A-immunized animals recognized only a limited subset of six to eight distinct P. yoelii antigens, primarily associated with the pAg fraction. These results provide the basis for the identification and characterization of potential vaccine antigens, selected solely for their ability to immunize against blood-stage malaria.

Full Text

The Full Text of this article is available as a PDF (645.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bouharoun-Tayoun H., Druilhe P. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun. 1992 Apr;60(4):1473–1481. doi: 10.1128/iai.60.4.1473-1481.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brown K. N., Brown I. N., Hills L. A. Immunity to malaria. I. Protection against Plasmodium knowlesi shown by monkeys sensitized with drug-suppressed infections or by dead parasites in Freund's adjuvant. Exp Parasitol. 1970 Oct;28(2):304–317. doi: 10.1016/0014-4894(70)90101-3. [DOI] [PubMed] [Google Scholar]
  3. CURTAIN C. C., KIDSON C., CHAMPNESS D. L., GORMAN J. G. MALARIA ANTIBODY CONTENT OF GAMMA 2-7S GLOBULIN IN TROPICAL POPULATIONS. Nature. 1964 Sep 26;203:1366–1367. doi: 10.1038/2031366a0. [DOI] [PubMed] [Google Scholar]
  4. Chen J., Trounstine M., Alt F. W., Young F., Kurahara C., Loring J. F., Huszar D. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int Immunol. 1993 Jun;5(6):647–656. doi: 10.1093/intimm/5.6.647. [DOI] [PubMed] [Google Scholar]
  5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  6. Cohen J. Bumps on the vaccine road. Science. 1994 Sep 2;265(5177):1371–1373. doi: 10.1126/science.8073271. [DOI] [PubMed] [Google Scholar]
  7. Daly T. M., Long C. A. Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection. Infect Immun. 1996 Jul;64(7):2602–2608. doi: 10.1128/iai.64.7.2602-2608.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Day K. P., Marsh K. Naturally acquired immunity to Plasmodium falciparum. Immunol Today. 1991 Mar;12(3):A68–A71. doi: 10.1016/s0167-5699(05)80020-9. [DOI] [PubMed] [Google Scholar]
  9. Desowitz R. S. Plasmodium berghei: immunologic enhancement of antigen by adjuvant addition. Exp Parasitol. 1975 Aug;38(1):6–13. doi: 10.1016/0014-4894(75)90032-6. [DOI] [PubMed] [Google Scholar]
  10. Eling W. Ficoll fractionation for the separation of parasitized erythrocytes from malaria infected blood. Bull World Health Organ. 1977;55(1):105–114. [PMC free article] [PubMed] [Google Scholar]
  11. Finkelman F. D., Holmes J., Katona I. M., Urban J. F., Jr, Beckmann M. P., Park L. S., Schooley K. A., Coffman R. L., Mosmann T. R., Paul W. E. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol. 1990;8:303–333. doi: 10.1146/annurev.iy.08.040190.001511. [DOI] [PubMed] [Google Scholar]
  12. Freeman R. R., Trejdosiewicz A. J., Cross G. A. Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite. Nature. 1980 Mar 27;284(5754):366–368. doi: 10.1038/284366a0. [DOI] [PubMed] [Google Scholar]
  13. Groux H., Gysin J. Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. Res Immunol. 1990 Jul-Aug;141(6):529–542. doi: 10.1016/0923-2494(90)90021-p. [DOI] [PubMed] [Google Scholar]
  14. Hoffmann E. J., Weidanz W. P., Long C. A. Susceptibility of CXB recombinant inbred mice to murine plasmodia. Infect Immun. 1984 Mar;43(3):981–985. doi: 10.1128/iai.43.3.981-985.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hunter R. L., Kidd M. R., Olsen M. R., Patterson P. S., Lal A. A. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants. J Immunol. 1995 Feb 15;154(4):1762–1769. [PubMed] [Google Scholar]
  16. Janeway C. A., Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell. 1994 Jan 28;76(2):275–285. doi: 10.1016/0092-8674(94)90335-2. [DOI] [PubMed] [Google Scholar]
  17. Kenney J. S., Hughes B. W., Masada M. P., Allison A. C. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J Immunol Methods. 1989 Jul 26;121(2):157–166. doi: 10.1016/0022-1759(89)90156-7. [DOI] [PubMed] [Google Scholar]
  18. Kumar S., Gorden J., Flynn J. L., Berzofsky J. A., Miller L. H. Immunization of mice against Plasmodium vinckei with a combination of attenuated Salmonella typhimurium and malarial antigen. Infect Immun. 1990 Oct;58(10):3425–3429. doi: 10.1128/iai.58.10.3425-3429.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  20. Langhorne J., Gillard S., Simon B., Slade S., Eichmann K. Frequencies of CD4+ T cells reactive with Plasmodium chabaudi chabaudi: distinct response kinetics for cells with Th1 and Th2 characteristics during infection. Int Immunol. 1989;1(4):416–424. doi: 10.1093/intimm/1.4.416. [DOI] [PubMed] [Google Scholar]
  21. Locksley R. M., Scott P. Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function. Immunol Today. 1991 Mar;12(3):A58–A61. doi: 10.1016/S0167-5699(05)80017-9. [DOI] [PubMed] [Google Scholar]
  22. Majarian W. R., Daly T. M., Weidanz W. P., Long C. A. Passive immunization against murine malaria with an IgG3 monoclonal antibody. J Immunol. 1984 Jun;132(6):3131–3137. [PubMed] [Google Scholar]
  23. McColm A. A., Bomford R., Dalton L. A comparison of saponin with other adjuvants for the potentiation of protective immunity by a killed Plasmodium yoelii vaccine in the mouse. Parasite Immunol. 1982 Sep;4(5):337–347. doi: 10.1111/j.1365-3024.1982.tb00445.x. [DOI] [PubMed] [Google Scholar]
  24. Mitchell G. H., Richards W. H., Voller A., Dietrich F. M., Dukor P. Nor-MDP, saponin, corynebacteria, and pertussis organisms as immunological adjuvants in experimental malaria vaccination of macaques. Bull World Health Organ. 1979;57 (Suppl 1):189–197. [PMC free article] [PubMed] [Google Scholar]
  25. Murphy J. R., Lefford M. J. Host defenses in murine malaria: induction of a protracted state of immunity with a formalin-killed Plasmodium berghei blood parasite vaccine. Infect Immun. 1978 Dec;22(3):798–803. doi: 10.1128/iai.22.3.798-803.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Playfair J. H., De Souza J. B., Cottrell B. J. Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei. Immunology. 1977 Oct;33(4):507–515. [PMC free article] [PubMed] [Google Scholar]
  27. Playfair J. H., De Souza J. B. Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice. Clin Exp Immunol. 1987 Jan;67(1):5–10. [PMC free article] [PubMed] [Google Scholar]
  28. Reese R. T., Trager W., Jensen J. B., Miller D. A., Tantravahi R. Immunization against malaria with antigen from Plasmodium falciparum cultivated in vitro. Proc Natl Acad Sci U S A. 1978 Nov;75(11):5665–5668. doi: 10.1073/pnas.75.11.5665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Scott P., Kaufmann S. H. The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today. 1991 Oct;12(10):346–348. doi: 10.1016/0167-5699(91)90063-Y. [DOI] [PubMed] [Google Scholar]
  30. Seder R. A., Paul W. E. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol. 1994;12:635–673. doi: 10.1146/annurev.iy.12.040194.003223. [DOI] [PubMed] [Google Scholar]
  31. Siddiqui W. A. An effective immunization of experimental monkeys against a human malaria parasite, Plasmodium falciparum. Science. 1977 Jul 22;197(4301):388–389. doi: 10.1126/science.406671. [DOI] [PubMed] [Google Scholar]
  32. Siddiqui W. A., Taylor D. W., Kan S. C., Kramer K., Richmond-Crum S. M., Kotani S., Shiba T., Kusumoto S. Vaccination of experimental monkeys against Plasmodium falciparum: a possible safe adjuvant. Science. 1978 Sep 29;201(4362):1237–1239. doi: 10.1126/science.99814. [DOI] [PubMed] [Google Scholar]
  33. Svetić A., Finkelman F. D., Jian Y. C., Dieffenbach C. W., Scott D. E., McCarthy K. F., Steinberg A. D., Gause W. C. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol. 1991 Oct 1;147(7):2391–2397. [PubMed] [Google Scholar]
  34. Süss G., Pink J. R. A recombinant malaria protein that can induce Th1 and CD8+ T cell responses without antibody formation. J Immunol. 1992 Aug 15;149(4):1334–1339. [PubMed] [Google Scholar]
  35. Targett G. A., Fulton J. D. Immunization of rhesus monkeys against Plasmodium knowlesi malaria. Exp Parasitol. 1965 Oct;17(2):180–193. doi: 10.1016/0014-4894(65)90020-2. [DOI] [PubMed] [Google Scholar]
  36. Taylor-Robinson A. W., Phillips R. S., Severn A., Moncada S., Liew F. Y. The role of TH1 and TH2 cells in a rodent malaria infection. Science. 1993 Jun 25;260(5116):1931–1934. doi: 10.1126/science.8100366. [DOI] [PubMed] [Google Scholar]
  37. Taylor D. W., Pacheco E., Evans C. B., Asofsky R. Inbred mice infected with Plasmodium yoelii differ in their antimalarial immunoglobulin isotype response. Parasite Immunol. 1988 Jan;10(1):33–46. doi: 10.1111/j.1365-3024.1988.tb00201.x. [DOI] [PubMed] [Google Scholar]
  38. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Weidanz W. P., Long C. A. The role of T cells in immunity to malaria. Prog Allergy. 1988;41:215–252. [PubMed] [Google Scholar]
  40. White W. I., Evans C. B., Taylor D. W. Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii. Infect Immun. 1991 Oct;59(10):3547–3554. doi: 10.1128/iai.59.10.3547-3554.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wynn T. A., Eltoum I., Cheever A. W., Lewis F. A., Gause W. C., Sher A. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol. 1993 Aug 1;151(3):1430–1440. [PubMed] [Google Scholar]
  42. ten Hagen T. L., Sulzer A. J., Kidd M. R., Lal A. A., Hunter R. L. Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines. J Immunol. 1993 Dec 15;151(12):7077–7085. [PubMed] [Google Scholar]
  43. van der Heyde H. C., Huszar D., Woodhouse C., Manning D. D., Weidanz W. P. The resolution of acute malaria in a definitive model of B cell deficiency, the JHD mouse. J Immunol. 1994 May 1;152(9):4557–4562. [PubMed] [Google Scholar]
  44. von der Weid T., Kitamura D., Rajewsky K., Langhorne J. A dual role for B cells in Plasmodium chabaudi chabaudi (AS) infection? Res Immunol. 1994 Jul-Aug;145(6):412–419. doi: 10.1016/s0923-2494(94)80170-3. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES